Panbela Therapeutics Shifts from Nasdaq to OTCQB Market
Company Announcements

Panbela Therapeutics Shifts from Nasdaq to OTCQB Market

Panbela Therapeutics (PBLA) has provided an update.

The board of directors of a company has decided to delist their common stock from the Nasdaq Stock Market and transition to the OTCQB market. Despite failing to meet Nasdaq’s minimum stockholders’ equity requirement, resulting in suspension of trading on Nasdaq, the stock became eligible for quotation on the OTCQB under the symbol “PBLA”. The move to file a Form 25 for delisting from Nasdaq will not affect the stock’s eligibility on the OTCQB. A press release was issued announcing these changes, underscoring the company’s ongoing adaptation to market regulations.

Find detailed analytics on PBLA stock on TipRanks’ Stock Analysis page.

Related Articles
Christine BrownPBLA Upcoming Earnings Report: What to Expect?
TheFlyPanbela announces first patient enrolled in dose escalation study of CPP-1X-S
Christine BrownIs PBLA a Buy, Before Earnings?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App